Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Melody Wu leads the firm’s practice in patent portfolio counseling. She advises on patent lifecycle planning, filing and claiming strategy, correction of patent issues before and after grant, policy issues affecting the patent system, and options and best practices for intellectual property protection. Ms. Wu directs the strategy for the worldwide patent portfolios covering several major pharmaceutical products and candidates. She acts as a special consultant regarding patent and patent office issues in contexts such as pre-litigation case assessment, due diligence for transactions, inter partes review, and patent litigation. Ms. Wu holds degrees from Harvard University and the Duke University School of Law and has experience with technical subject matter including biofuels, vaccines, speech synthesis, cognitive training software, gene expression, fusion proteins, hypersonic engines, and RF shielding.

  • Advice on patent strategy in coordination with regulatory strategy for pharmaceutical products in Europe, Japan, Australia, China, Canada, Brazil, India, Korea, Mexico, and Eurasia.
  • Development of an intellectual property policy and manual for a multinational corporation.
  • Advice on benefits and drawbacks of supplemental exam, reissue, and ex parte reexam options to strengthen patents in advance of third-party challenge.
  • Development of strategy resulting in accelerated grant of four new patents eligible for Orange Book listing, prior to conclusion of inter partes review proceedings against already-listed patents.
  • Correction of complex problems in patent assignments and chain of title, particularly in the context of acquisitions.
  • Advice on IP issues concerning the production and packaging of wines and other beverages.
  • Evaluation of a portfolio relating to iron and other metal chelators in connection with a semi-public offering.
  • Representation of a pharmaceutical company in patent litigation relating to medical devices.
  • Advice on patent term adjustment and term extension regimes in connection with Transatlantic Trade and Investment Partnership negotiations.

Pro Bono

  • Advising on the incorporation of a not-for-profit organization for funding carbon sequestration projects.
  • Advising Mana Nutrition on issues concerning ready-to-use therapeutic food for treating malnutrition in children.